glp 1 and sun exposure A Closer Look at the Dermatological Profile of GLP-1 Agonists Tanning on Semaglutide: Sun Safety

Compare psyllium, methylcellulose, inulin, and more with dosing protocols.

Craig Primack, Hims & Hers SVP of Weight Management, joins 'Closing Bell Overtime' to talk the company offering a GLP-1 drug through its platform.

This review summarises recent advances in the understanding of diabetic gastroparesis, with an emphasis on the current therapies that influence GE, and the bidirectional relationship between glycaemic control and GE.

That is the conclusion of a retrospective study published online on Jan

The GLP-1 Market size was valued at USD 52.82 billion in 2025 and is expected to grow at a CAGR of 10.9% from 2026 to 2034.

Tirzepatide, a novel GLP-1/GIP dual receptor agonist, shows significant advantages in glycemic management and weight control